BD has made available the BD Ultra-Fine Nano, a 4mm x 32G pen needle. The BD Ultra-Fine Nano pen needle has been shown to be as effective as longer needles for patients of all body types with diabetes who inject insulin or glucagon-like peptide 1 (GLP-1). Clinical trials demonstrated that insulin injections with the BD Ultra-Fine Nano provide equivalent glucose control to longer insulin pen needles. The BD Ultra-Fine Nano effectively delivers an insulin dose to subcutaneous tissue while reducing the risk of injecting into muscle. Additionally, the short length and thin gauge of this pen needle may help patients with diabetes better adhere to an injection regimen by lessening pain experienced upon injection.

For more information call (888) 232-2737 or visit www.bd.com.